InMed Pharmaceuticals Inc (INM)

[Aladdin80]

I can assure you that there's little comfort to be had w/InMed. Unless investors like yourself are taking comfort in losing money. Or investors take comfort in reducing their share count by 33:1. Or investors take comfort in knowing that their only real clinical candidate looking at a large patient pool doesn't even touch the clinic until late '21. Given InMed's history, expect that more realistically be '22.

Or investors take comfort in knowing that what was once romanticized as a potential homerun investment may yield nothing more than a walk or a single. At this stage many will need a double digit SP simply to break even. What that means is maybe, just maybe, they drop that whale sized news that has eluded them for so long and she'll run maybe just enough for you to cash in your chips for what you put in "x" years ago. Pre-split shareholders, especially during consolidations of this size with immediate down trends, are the equivalent of collateral damage.

Unfortunately we now know in hind-sight that they stumbled, very late, into what their peers already knew. This being the hard truth that a prokaryotic host was not feasible to biosynthetically scale cannabinoids.